AMP 2019
BEST-CLI: Trial Update
08/14/2019
Richard Neville, MD, offers an update on the goals and design of the BEST-CLI (Best Endovascular vs Best Surgical Therapy for Patients With Critical Limb Ischemia) trial, a multidisciplinary study.
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:
Subscribe Now!
Vascular Disease Management Newsletter




